|
Patent landscape, scope, and claims: |
Understanding the Scope and Claims of United States Patent 6,096,742
Introduction to the Patent
United States Patent 6,096,742, titled "Polymorphic form of a tachykinin receptor antagonist," is a significant patent in the pharmaceutical domain. This patent, granted to MSD (Merck & Co., Inc.), pertains to a novel polymorphic form of a specific compound and its pharmaceutical formulations.
Patent Overview
The patent, published on August 1, 2000, describes a novel polymorphic form of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)-phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine)[4].
Claims of the Patent
The patent includes several key claims that define its scope:
Compound and Polymorphic Form
- The primary claim is for the novel polymorphic form of the specified compound, which is a tachykinin receptor antagonist.
- This polymorphic form is distinguished by its unique physical and chemical properties, which are crucial for its stability and efficacy[4].
Pharmaceutical Formulations
- The patent also claims pharmaceutical formulations that include this novel polymorphic form as an active ingredient.
- These formulations are designed for the treatment of various disorders, including those of the central nervous system, inflammatory diseases, pain, migraine, asthma, and emesis[4].
Methods of Use
- The claims extend to the use of the compound and its formulations in treating or preventing the aforementioned disorders.
- This includes specific therapeutic applications where the tachykinin receptor antagonist is beneficial[4].
Patent Landscape Analysis
Competitive Landscape
To understand the broader context of this patent, a patent landscape analysis is essential. This analysis reveals the competitive landscape in the pharmaceutical industry, particularly in the domain of tachykinin receptor antagonists.
- Market Developments: The analysis would include market trends, such as mergers and acquisitions, in/out-licensing agreements, and litigation activities related to similar patents. This helps in identifying potential competitors and collaborators[3].
Patent Trends
- The analysis would highlight patent trends, including the number of patents filed and granted in this domain over time.
- It would also identify key players and their patent portfolios, providing insights into the technological advancements and innovations in the field[3].
Legal Status and Expiry Dates
- The legal status of the patent, including whether it is alive, pending, lapsed, revoked, or expired, is crucial.
- For US Patent 6,096,742, the patent has expired, which means that the exclusive rights to the invention are no longer in effect[4].
Geographical Scope
- The patent landscape analysis would also consider the geographical scope of similar patents.
- While the specific patent in question is for the United States, similar patents may exist in other countries, as seen in the extensive list of patents held by MSD across various jurisdictions[1].
Tools and Methods for Analysis
Performing a thorough patent landscape analysis involves several tools and methods:
Computer Tools and Human Intelligence
- Advanced computer tools are used to analyze and organize vast amounts of patent data.
- Human intelligence is also crucial for interpreting and extracting valuable insights from this data[3].
Reporting Formats
- The analysis can be reported in various formats, including World Intellectual Property Organization reports, 3D maps, and MS Excel spreadsheets.
- Statistical graphs and figures are often included to make the report more interpretable and valuable[3].
Insights and Applications
Business and Legal Insights
- The insights gained from the patent landscape analysis can be applied to legal, business, and technical decision-making.
- For instance, understanding the legal status and expiry dates of patents can help in planning product launches or licensing agreements[3].
Minimizing Risks and Capitalizing on Opportunities
- The analysis helps in identifying potential risks, such as litigation or opposition activities, and opportunities, such as in/out-licensing or collaborations.
- This enables organizations to make informed decisions and capitalize on market opportunities while minimizing associated risks[3].
Industry Expert Perspectives
"Patent landscape analysis is a powerful tool for understanding the competitive landscape and identifying opportunities for innovation and collaboration. It provides a comprehensive view of the technological domain, helping businesses to navigate complex patent landscapes effectively."[3]
Illustrative Statistics
- According to industry reports, the number of pharmaceutical patents filed annually has been increasing, reflecting the growing importance of intellectual property in the industry.
- For example, in 2020, over 150,000 pharmaceutical patents were filed worldwide, indicating a highly competitive and innovative field[3].
Examples and Case Studies
- A case study involving Celgene Corp. and Barr Laboratories Inc. highlights the importance of patent disputes in the pharmaceutical industry. Resolving such disputes can significantly impact market strategies and product development[2].
Key Takeaways
- Patent Scope: US Patent 6,096,742 covers a novel polymorphic form of a tachykinin receptor antagonist and its pharmaceutical formulations.
- Claims: The patent includes claims for the compound, its polymorphic form, pharmaceutical formulations, and methods of use.
- Patent Landscape: A thorough analysis reveals the competitive landscape, patent trends, and legal status, aiding in business and legal decision-making.
- Tools and Methods: Advanced computer tools and human intelligence are used to analyze and report patent data.
- Insights and Applications: The analysis provides valuable insights for minimizing risks and capitalizing on opportunities in the pharmaceutical industry.
Frequently Asked Questions (FAQs)
Q: What is the primary claim of US Patent 6,096,742?
A: The primary claim is for a novel polymorphic form of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)-phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine)[4].
Q: What are the therapeutic applications of the compound covered by this patent?
A: The compound is used in treating or preventing disorders of the central nervous system, inflammatory diseases, pain, migraine, asthma, and emesis[4].
Q: Has the patent expired?
A: Yes, US Patent 6,096,742 has expired, meaning the exclusive rights to the invention are no longer in effect[4].
Q: What is the importance of patent landscape analysis in the pharmaceutical industry?
A: Patent landscape analysis helps in understanding the competitive landscape, identifying market trends, and making informed business and legal decisions[3].
Q: How can organizations benefit from patent landscape analysis?
A: Organizations can benefit by identifying opportunities for innovation and collaboration, minimizing risks, and capitalizing on market opportunities[3].
Sources Cited
- MSD Patent Information site - Product patents - MSD
- Patent Docs - Biotech/Pharma Docket
- Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis
- Google Patents - US6096742A - Polymorphic form of a tachykinin receptor antagonist
More… ↓
⤷ Subscribe
|
